Candriam SCA’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $450K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $18M | Hold |
|
|||||
|
2020
Q4 | $18.8M | Sell |
|
|||||
|
2020
Q3 | $15.3M | Hold |
|
|||||
|
2020
Q2 | $24.4M | Buy |
|
|||||
|
2020
Q1 | $23.1M | Hold |
|
|||||
|
2019
Q4 | $23.6M | Sell |
|
|||||
|
2019
Q3 | $15.8M | Sell |
|
|||||
|
2019
Q2 | $23.4M | Hold |
|
|||||
|
2019
Q1 | $21.3M | Buy |
|
|||||
|
2018
Q4 | $11.2M | Buy |
|
|||||
|
2018
Q3 | $16M | Buy |
|
|||||
|
2018
Q2 | $5.13M | Buy |
|
|||||
|
2018
Q1 | $1.89M | Hold |
|
|||||
|
2017
Q4 | $2.6M | Buy |
|
|||||
|
2017
Q3 | $1.87M | Buy |
|